S. 2274: Dextromethorphan Abuse Reduction Act of 2007
Before you vote › Federal bills
S. 2274: Dextromethorphan Abuse Reduction Act of 2007
110th Congress · introduced 2007-10-31 · Crime and Law Enforcement · Latest: Committee on the Judiciary Senate Subcommittee on Crime and Drugs. Hearings held.
federal
Follow this bill, step by step
- Where it came from: introduced 2007-10-31 · official record
- Who proposed it: Sen. Biden, Joseph R., Jr. [D-DE] · what a sponsor is
- What happened next: no floor votes in our records yet. Why?
- Where it stands now: Committee on the Judiciary Senate Subcommittee on Crime and Drugs. Hearings held. Not final yet: this can still change. We check for updates every day.
- If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.
Official title
Dextromethorphan Abuse Reduction Act of 2007
Plain summary
Dextromethorphan Abuse Reduction Act of 2007 - Amends the Controlled Substances Act to: (1) set forth definitions relating to dextromethorphan in unfinished or finished dosage form; (2) classify unfinished dextromethorphan as a Schedule V controlled substance; and (3) impose civil penalties for sales of products containing dextromethorphan to individuals under the age of 18. Expresses the sense of the Senate that: (1) manufacturers of products containing dextromethorphan should provide warnings about the dangers of dextromethorphan misuse; and (2) retailers should impose safeguards to protect against the theft of products containing dextromethorphan. Directs the Director of National Drug Control Policy to make grants to the Partnership for a Drug-Free America and the Community Anti-Drug Coalition of America for education programs to prevent the abuse of prescription and nonprescription drugs (including dextromethorphan). Authorizes the Administrator of the Substance Abuse and Mental Health Services Administration to make grants to certain communities to implement comprehensive community-wide strategies for addressing abuse of prescription and nonprescription drugs.
Congressional Research Service summary (Introduced in Senate), quoted unchanged (nonpartisan). Read the source.
What a vote does
A “Yea” vote
If it passes both chambers and is signed, it becomes law.
A “Nay” vote
If it is not passed, current law stays as it is.
PSI Sci description of the legislative step (not an opinion).
What does this mean? (plain words)
Official text
Dextromethorphan Abuse Reduction Act of 2007
Source: Congressional Research Service summary (Introduced in Senate)
AI explanation – may be wrong, check the official text
No AI explanation yet. It takes up to a minute to write and is then saved for everyone.
Limited to a few requests an hour per person.
The strongest published arguments
Arguments for (supporters)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Arguments against (opponents)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Alternatives
Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.
How did my representative vote? · This bill's floor votes
Officials and money
Sponsor: Sen. Biden, Joseph R., Jr. [D-DE] · 3 cosponsors
Cost estimate: No cost estimate published yet.
Cosponsors on this site
Chuck Grassley (R-IA), Richard J. Durbin (D-IL)
No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.
Sources
- Congressional Research Service summary (Introduced in Senate)
- Congress.gov
- Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-110s2274.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/110/s>
Record fed-us-cong110-s2274 · catalog fed-us-congress-bills-cong110 · updated 2026-11-15 by psicol fed-bills-cong110